GKOS · Glaukos Corp
Price
Snapshot
50 fields · last close| Market Cap | $9.66B |
| P/E | — |
| Float | 56.86M |
| Beta | 0.74 |
| Volatility | 18.5% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Mid cap |
| Macro sensitivity | Moderate |
| Clavix score | 71 |
| Price | 162.07 |
| Change | −1.06% |
| Prev Close | 163.81 |
| Open | 160.60 |
| Day Low | 159.01 |
| Day High | 163.85 |
| Avg Vol | 1 |
| Avg $ Vol | $134.5M |
| 52W High | 191.62 |
| 52W Low | 73.16 |
| 52W Pos | 75.1% |
| From High | −15.42% |
| From Low | +121.53% |
| Max DD 1Y | −28.39% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | −7.96% |
| SMA 50 | −5.20% |
| SMA 200 | +22.32% |
| RSI (14) | 39.6 |
| Vol 30D | 37.8% |
| Vol 90D | 48.0% |
| 1Y Range | 73–192 |
| Daily bars | 516 |
| Perf Week | −2.06% |
| Perf Month | −13.58% |
| Perf Quarter | +25.35% |
| Perf Half Y | +60.46% |
| Perf Year | +99.52% |
| Perf YTD | +46.38% |
| Prev Day | −1.06% |
| Clavix | B- |
| Debt / Eq | 0.11 |
| Curr Ratio | 4.69 |
| Int Cover | -74.1× |
| FCF Margin | 2.5% |
| Rev Growth | +49.5% |
| Profit | Unprofitable |
| Leverage | Low |
| Sector rank | 35 / 47 |
Clavix risk grade
regraded every trading dayGKOS grades B-, 71 of 100. Steadiest on News Sentiment (69), most exposed on Price Stability (52, mixed). 2 of the 4 weighted dimensions sit above the Health Care median. Ranks 35 of 47 in Health Care by Clavix score.
How rough the ride is
| GKOS | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.74 | 0.85 |
| Volatilityannualized | 18.5% | 21.2% |
| Max drawdown, past yearworst peak-to-trough fall | −28.4% | — |
| Typical daily movemedian absolute daily change | 1.60% | — |
| Days beyond ±3%of the last 252 sessions | 5421% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| GKOS | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.74 | 0.85 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| GKOS | |
|---|---|
| 1 week | −2.1% |
| 1 month | −13.6% |
| Year to date | +46.4% |
| 1 year | +99.5% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| GKOS | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 22since 27 Jul |
| Average score0 most bearish, 100 most bullish | 70 |
| Bullish · bearisharticles above 60 · below 40 | 20 · 1 |
| Directionarticles whose tone is improving vs worsening | 20 ↑ 1 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| GKOS | |
|---|---|
| Revenue growthyear over year | +49.5% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openBank of America Corp DE disclosed a new purchase of 587,327 shares of Glaukos Corporation (GKOS) during the second quarter, according to its SEC filing.
Jefferies Financial Group opened a new position in Glaukos during the second quarter, buying 7,856 shares worth about $1.10 million, according to its SEC filing. The article does not include further information.
Braun Stacey Associates Inc. opened a new position in Glaukos Corporation (NYSE: GKOS) during the second quarter, buying 55,010 shares, according to an SEC disclosure. The article is cut off and does not include the dollar value of the purchase or the price per share paid.
Zacks Research lowered its Q2 2027 earnings-per-share estimate for Glaukos in a research note issued on Wednesday, August 19th. The article body is truncated and does not provide further detail.
An analyst article recommends holding Glaukos stock, citing its iDose TR and Epioxa products as drivers of rapid growth, expanding profit margins, and a broad pipeline as supporting long-term prospects.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| PODD | Insulet Corp | C+ | $9.75B | 25.98 | 1.08 | Compare |
| HSIC | Henry Schein Inc | A- | $9.46B | 23.46 | 0.87 | Compare |
| GMED | Globus Medical Inc | B | $9.95B | 18.58 | 1.00 | Compare |
| UHS | Universal Health Services Inc | A- | $10.41B | 6.82 | 1.12 | Compare |
| MOH | Molina Healthcare Inc | B | $10.48B | 22.21 | 0.73 | Compare |
| ALGN | Align Technology Inc | B- | $10.49B | 25.35 | 1.74 | Compare |
| COO | Cooper Companies Inc | B- | $10.51B | 18.44 | 0.84 | Compare |
| BTSG | Brightspring Health Services Inc | B- | $11.23B | 30.70 | 1.89 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.